zoledronic acid has been researched along with Fibrosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashihara, E; Fushiki, S; Horie, N; Itoi, M; Kimura, S; Koto, K; Kubo, T; Maekawa, T; Matsui, T; Murata, H; Nishigaki, Y; Ryu, K; Sakabe, T | 1 |
| Ashihara, E; Fushiki, S; Horie, N; Kimura, S; Koto, K; Kubo, T; Maekawa, T; Matsui, T; Murata, H; Ryu, K; Sawai, Y | 1 |
2 other study(ies) available for zoledronic acid and Fibrosarcoma
| Article | Year |
|---|---|
Zoledronic acid inhibits proliferation of human fibrosarcoma cells with induction of apoptosis, and shows combined effects with other anticancer agents.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Density Conservation Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Dose-Response Relationship, Drug; Down-Regulation; Drug Evaluation, Preclinical; Drug Synergism; Fibrosarcoma; Humans; Imidazoles; Time Factors; Zoledronic Acid | 2010 |
Zoledronic acid significantly enhances radiation‑induced apoptosis against human fibrosarcoma cells by inhibiting radioadaptive signaling.
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Diphosphonates; Fibrosarcoma; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Radiation, Ionizing; Reactive Oxygen Species; Zoledronic Acid | 2013 |